L and J-HZ is under clinical development by L&J Bio and currently in Phase I for Herpes Zoster (Shingles).
Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe – Biotech Investments
Biophytis / Key word(s): Miscellaneous Biophytis receives a positive opinion for its SARA-31 phase 3 study in sarcopenia in Europe 08-Aug-2023 / 07:00 CET/CEST